The performance of solar cells with a polymer:polymer bulk heterojunction (BHJ) structure, consisting of poly[4,8-bis(5-(2-ethylhexyl)thiophen-2-yl)benzo[1,2-b:4,5-b']dithiophene-alt-3-fluorothieno[3,4-b]thiophene-2-carboxylate] (PTB7-Th) donor and poly[[N,N'-bis(2-octyldodecyl)-naphthalene-1,4,5,8-bis(dicarboximide)-2,6-diyl]-alt-5,5'-(2,2'-bithiophene)] (P(NDI2OD-T2)) acceptor polymers, was investigated as a function of cosolvent (p-xylene:chlorobenzene (pXL:CB)) composition ratio. A remarkable efficiency improvement (∼38%) was achieved by spin-coating the photoactive blend layer from pXL:CB = 80:20 (volume) rather than pXL alone, but the efficiency then decreased when the CB content increased further to pXL:CB = 60:40. The improved efficiency was correlated with a particular PTB7-Th:P(NDI2OD-T2) donor-acceptor blend nanostructure, evidenced by a fiber-like surface morphology, a red-shifted optical absorption, and enhanced PL quenching. Further device optimization for pXL:CB = 80:20 films yielded a power conversion efficiency of ∼5.4%. However, these devices showed very poor stability (∼15 min for a 50% reduction in initial efficiency), owing specifically to degradation of the PTB7-Th donor-component. Replacing PTB7-Th with a more stable donor polymer will be essential for any application potential to be realized.
No takes yet. Share an insight, caveat, or question.
Nam et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: